drugset / Trial / NCT03156738
A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to investigate the safety, tolerability, pharmacokinetics and immunogenicity of MT-2990 in healthy male subjects.
Timeline
- Start
- 2017-05-17
- Primary completion
- 2017-12-29
- Completion
- 2017-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MT-2990 | Unknown | — | Intravenous |
Indications
No indication recorded.